Yang, H.-C
The trial design included a core study phase consisting of a four-week screening period, followed by a four-week baseline phase where participants received only a placebo in a single-blind manner, and then a 24-week randomized treatment phase, where participants received either bremelanotide or placebo [1]
It directly affects your energy levels, cell health, and brain function
It must be reminded that in our experience, IGF-1 treatment does not only raise IGF-1 plasma levels, but also stimulates tissues to synthesise their own IGF-1 by a mechanism still not uncovered, aiming these mechanisms of central stimulation of peripheral improvement
Bigelow MW, Wiessner JH, Kleinman JG, Mandel NS (1997) The dependence on membrane fluidity of calcium oxalate crystal attachment to IMCD membranes